TP53 and small cell lung carcinoma: We employed bulk DynaTag and single-nuclei RNA-seq (snRNA-seq) to study chemotherapy treatments in a PDX model for SCLC, which harboured mutations in TP53 and TP73, and predominant expression of ASCL1 (Fig. 4A and Supplementary Fig. 5)26.